Sarepta Therapeutics to Present Company Overview at the 2013 31st Annual JP Morgan Healthcare Conference

Webcast Accessible via Sarepta Therapeutics Website

(firmenpresse) - CAMBRIDGE, MA -- (Marketwire) -- 12/28/12 -- Sarepta Therapeutics (NASDAQ: SRPT), a developer of innovative RNA-based therapeutics, announced today that it is scheduled to present at the 2013 31st Annual JP Morgan Healthcare Conference in San Francisco, CA on Wednesday, January 9, 2013 at 4:30pm Pacific Time. Chris Garabedian, Sarepta's President and CEO, will be the presenter.

The presentation will be webcast live under the events section of Sarepta Therapeutics' website at and will be archived there following the presentation for 90 days. Please connect to Sarepta's website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.



Sarepta Therapeutics is focused on developing first-in-class RNA-based therapeutics to improve and save the lives of people affected by serious and life-threatening rare and infectious diseases. The Company's diverse pipeline includes its lead program eteplirsen, for Duchenne muscular dystrophy, as well as potential treatments for some of the world's most lethal infectious diseases. Sarepta aims to build a leading, independent biotech company dedicated to translating its RNA-based science into transformational therapeutics for patients who face significant unmet medical needs. For more information, please visit us at .



Sarepta Media and Investor Contact:
Erin Cox
425.354.5140

Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: MARKETWIRE
Datum: 28.12.2012 - 13:30 Uhr
Sprache: Deutsch
News-ID 215808
Anzahl Zeichen: 0

contact information:
Town:

CAMBRIDGE, MA

Kategorie:

Drugs

Diese Pressemitteilung wurde bisher 365 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Sarepta Therapeutics to Present Company Overview at the 2013 31st Annual JP Morgan Healthcare Conference"
steht unter der journalistisch-redaktionellen Verantwortung von

Sarepta Therapeutics, Inc. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

Sarepta Therapeutics to Present Company Overview at Upcoming Conferences ...

CAMBRIDGE, MA -- (Marketwired) -- 11/19/13 -- Sarepta Therapeutics (NASDAQ: SRPT), a developer of innovative RNA-based therapeutics, announced today that it is scheduled to present at the following investor conferences in December. Chris Garabedian, ...

Sarepta Therapeutics Announces Third Quarter 2013 Financial Results and Recent C ...

CAMBRIDGE, MA -- (Marketwired) -- 11/12/13 -- Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a developer of innovative RNA-based therapeutics, today reported financial results for the three and nine months ended September 30, 2013, and provided an updat ...

Sarepta Therapeutics Announces FDA Considers NDA Filing for Eteplirsen Premature ...

CAMBRIDGE, MA -- (Marketwired) -- 11/12/13 -- Sarepta Therapeutics, Inc. (NASDAQ: SRPT) today provided an update on its discussions with the U.S. Food and Drug Administration (FDA) regarding its planned New Drug Application (NDA) submission and conf ...

Alle Meldungen von Sarepta Therapeutics, Inc.